Zymeworks (ZYME) Cash from Financing Activities (2021 - 2025)
Zymeworks' Cash from Financing Activities history spans 3 years, with the latest figure at $50.6 million for Q4 2023.
- For Q4 2023, Cash from Financing Activities rose 13530.24% year-over-year to $50.6 million; the TTM value through Dec 2023 reached $81.9 million, down 24.6%, while the annual FY2025 figure was -$18.6 million, 9.19% up from the prior year.
- Cash from Financing Activities for Q4 2023 was $50.6 million at Zymeworks, up from $1.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $108.6 million in Q1 2022 and bottomed at -$377000.0 in Q4 2022.
- The 3-year median for Cash from Financing Activities is $1.7 million (2023), against an average of $21.2 million.
- The largest annual shift saw Cash from Financing Activities tumbled 154.72% in 2022 before it surged 13530.24% in 2023.
- A 3-year view of Cash from Financing Activities shows it stood at $689000.0 in 2021, then crashed by 154.72% to -$377000.0 in 2022, then soared by 13530.24% to $50.6 million in 2023.
- Per Business Quant, the three most recent readings for ZYME's Cash from Financing Activities are $50.6 million (Q4 2023), $1.9 million (Q3 2023), and $27.6 million (Q2 2023).